Latest filing published 02 Mar 2026 for Merit Medical Systems INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Raul Parra Jr., listed as finance chief, appears in our data through filings on Merit Medical Systems Inc shares, published by SEC (Form 4). The record holds 57 filings, for trades running from 13 March 2019 to 26 February 2026.
Market trades split into 1 purchase (€58k) and 18 sales (€8.6M). Taken together, the sales exceed the purchases by €8.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 16 share grants and 20 option exercises.
On 2 March 2026 came the latest disclosure, a share grant in Merit Medical Systems Inc. The most recent open-market purchase was published on 5 November 2019, 2,544 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations